Related references
Note: Only part of the references are listed.Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease
Lars Gullestad et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2012)
NPY receptors as potential targets for anti-obesity drug development
Ernie Yulyaningsih et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Of Mice and Men: Neuropeptide Y and Its Receptors Are Associated with Atherosclerotic Lesion Burden and Vulnerability
Lijun Li et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2011)
Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats
Dwayne N. Jackson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
A possible role of neuropeptide Y in depression and stress
Julio Cesar Morales-Medina et al.
BRAIN RESEARCH (2010)
Adrenal Responses to Stress
David S. Goldstein
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss
Nora E. Straznicky et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
Shaun P. Brothers et al.
EMBO MOLECULAR MEDICINE (2010)
Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition
Ken Abe et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety
Annika Thorsell
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Adaptation to extreme stress: post-traumatic stress disorder, neuropeptide Y and metabolic syndrome
Ann M. Rasmusson et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Metoprolol, but not atenolol, reduces stress induced neuropeptide Y release in pigs
Bengt Ablad et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2010)
Coordinated Regulation of Foraging and Metabolism in C-elegans by RFamide Neuropeptide Signaling
Merav Cohen et al.
CELL METABOLISM (2009)
Purines as Neurotransmitters and Neuromodulators in Blood Vessels
Vera Ralevic
CURRENT VASCULAR PHARMACOLOGY (2009)
Chronic Stress, Combined with a High-Fat/High-Sugar Diet, Shifts Sympathetic Signaling toward Neuropeptide Y and Leads to Obesity and the Metabolic Syndrome
Lydia E. Kuo et al.
STRESS, NEUROTRANSMITTERS, AND HORMONES: NEUROENDOCRINE AND GENETIC MECHANISMS (2008)
Early vertebrate chromosome duplications and the evolution of the neuropeptide Y receptor gene regions
Tomas A. Larsson et al.
BMC EVOLUTIONARY BIOLOGY (2008)
Neuropeptide Y receptor-specifically modulates human neutrophil function
Sammy Bedoui et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
NPY and its involvement in axon guidance, neurogenesis, and feeding
Tomas Hokfelt et al.
NUTRITION (2008)
Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure
Ean Y. Callanan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Intracellular signaling mechanisms mediating catecholamine release upon activation of NPYY1 receptors in mouse chromaffin cells
Joana Rosmaninho-Salgado et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome
Lydia E. Kuo et al.
NATURE MEDICINE (2007)
Stress, NPY and vascular remodeling: Implications for stress-related diseases
Lydia E. Kuo et al.
PEPTIDES (2007)
NPY and cardiac diseases
B. J. McDermott et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Evolutionary conservation of neuropeptide expression in the thymus of different species
AB Silva et al.
IMMUNOLOGY (2006)
A fundamental bimodal role for neuropeptide Y1 receptor in the immune system
J Wheway et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles
JB Buckwalter et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors
LJ Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors
J Kitlinska et al.
CANCER RESEARCH (2005)
Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro:: counter regulation through Y1 and Y2/5 receptors
M Dimitrijevic et al.
REGULATORY PEPTIDES (2005)
Learning new tricks from old dogs:: β-adrenergic receptors teach new lessons on firing up adipose tissue metabolism
S Collins et al.
MOLECULAR ENDOCRINOLOGY (2004)
Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?
A Vezzani et al.
NEUROPEPTIDES (2004)
Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission
MV Donoso et al.
JOURNAL OF VASCULAR RESEARCH (2004)
Y1- and α1-receptor control of basal hindlimb vascular tone
DN Jackson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle
H Zhang et al.
CIRCULATION RESEARCH (2004)
Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization
M Koulu et al.
ANNALS OF MEDICINE (2004)
Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery
LJ Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The effect of a neuropeptide YY1 receptor antagonist in patients with angina pectoris
L Gullestad et al.
EUROPEAN HEART JOURNAL (2003)
Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing
AJ Ekstrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hypotension and reduced catecholamines in neuropeptide Y transgenic rats
M Michalkiewicz et al.
HYPERTENSION (2003)
Neuropeptide Y: A novel mechanism for ischemic angiogenesis
Z Zukowska et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men
MK Karvonen et al.
ATHEROSCLEROSIS (2001)
Cross-talk between sympathetic neurons and adipocytes in coculture
LC Turtzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The effect of acute and chronic restraint on the central expression of prepro-neuropeptide Y mRNA in normotensive and hypertensive rats
BW Sweerts et al.
JOURNAL OF NEUROENDOCRINOLOGY (2001)
Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions
M De la Fuente et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding
G Ghersi et al.
PEPTIDES (2001)
Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool-aged children
MK Karvonen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPYY5 receptors
C Pellieux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Corticotropin releasing hormone neurons in the paraventricular nucleus are direct targets for neuropeptide Y neurons in the arcuate nucleus: an anterograde tracing study
C Li et al.
BRAIN RESEARCH (2000)
Share Paper
